Bizarre Patents
Neuroimaging as a Marketing Tool
Neuroimaging as a means for validating whether a stimulus such as advertisement, communication, or product evokes a certain mental response such as emotion, preference, or memory, or to predict the consequences of the stimulus on later behavior such as consumption or purchasing.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6312409 | Device for generating a pulsatile fluid drug flow A device (10) for generating a pulsatile fluid drug flow comprises a housing (11) containing an expandable-contractible chamber (12) having an inlet (14) and an outlet (15), a valve (16) associated with the outlet (15) which is actuated by the expansion a... | 11/06/2001 |
| 5641515 | Controlled release biodegradable nanoparticles containing insulin A controlled release pharmaceutical formulation comprises nanoparticles formed of a biodegradable polycyanoacrylate polymer in which insulin is entrapped, the insulin being complexed to the polycyanoacrylate. These particles are capable of releasing bioac... | 06/24/1997 |
| 5641745 | Controlled release biodegradable micro- and nanospheres containing cyclosporin A controlled release pharmaceutical formulation which comprises cyclosporin entrapped in a biodegradable polymer to form microspheres or nanospheres such that the cyclosporin is substantially in an amorphous state and the biodegradable polymer comprises g... | 06/24/1997 |
| 5637320 | Controlled absorption naproxen formulation for once-daily administration A once-daily naproxen formulation for oral administration having a first portion of the naproxen as a multi-particulate pellet form, each pellet having a core of naproxen or a pharmaceutically acceptable salt thereof in association with an organic acid, t... | 06/10/1997 |
| 5616345 | Controlled absorption diltiazen formulation for once-daily administration A diltiazem pellet formulation for oral administration comprises a core of diltiazem or a pharmaceutically acceptable salt thereof in association with an organic acid, and a multi-layer membrane surrounding the core and containing a major proportion of a ... | 04/01/1997 |
| 5580580 | Formulations and their use in the treatment of neurological diseases Pharmaceutical formulations comprise a mono- or di-aminopyridine active agent for administration on a once- or twice-daily basis for use in the treatment of neurological diseases, in particular multiple sclerosis and Alzheimer's disease. The formulations,... | 12/03/1996 |
| 5540938 | Formulations and their use in the treatment of neurological diseases Pharmaceutical formulations comprise a mono- or di-aminopyridine active agent for administration on a once- or twice-daily basis for use in the treatment of neurological diseases, in particular multiple sclerosis and Alzheimer's disease. The formulations,... | 07/30/1996 |
| 5533995 | Passive transdermal device with controlled drug delivery A transdermal device for the controlled administration of a drug to the skin comprises a reservoir (12) for the drug and an electric circuit which includes an electrode system (13, 14) which is operable to actively transport the drug in a controlled manne... | 07/09/1996 |
| 5505962 | Controlled release pharmaceutical formulation An improved controlled release tablet formulation for the release of potassium chloride through a differentially permeable membrane from which the release of potassium chloride can be accurately controlled to minimize the likelihood of producing high loca... | 04/09/1996 |
| 5370879 | Formulations and their use in the treatment of neurological diseases Pharmaceutical formulations comprise a mono- or di-aminopyridine active agent for administration on a once- or twice-daily basis for use in the treatment of neurological diseases, in particular multiple sclerosis and Alzheimer's disease. The formulations,... | 12/06/1994 |
| 5354556 | Controlled release powder and process for its preparation A controlled release powder containing discrete micro-particles for use in edible, pharmaceutical and other controlled release compositions is disclosed. The micro-particles have an average size in the range of from 0.1 to 125 μm. Each of the micro-parti... | 10/11/1994 |
| 5336504 | Diltiazem formulations and methods of treatment A diltiazem pellet formulation for oral administration comprises a core of diltiazem or a pharmaceutically acceptable salt thereof in association with an organic acid, and a multi-layer membrane surrounding the core and containing a major proportion of a ... | 08/09/1994 |
| 5156842 | Liquid suspension for oral administration A non-aqueous pharmaceutical liquid suspension having improved bioavailability for oral administration comprises an active ingredient suspended in an edible, non-aqueous carrier vehicle such as an oil, wherein the active ingredient is in the form of contr... | 10/20/1992 |
| 5128142 | Sustained release drug delivery system A controlled release formulation comprising an adsorbate of a mixture of a pharmaceutically useful active ingredient and an inactive substance adsorbed on a cross-linked polymer. The inactive substance is selected to modify the dissolution of the active i... | 07/07/1992 |
| 5069904 | Method of using nicotine in the treatment of conditions susceptible to said treatment A method of using nicotine in the treatment of various conditions susceptible to alleviation by nicotine therapy such as disease states characterized by reduced central cholinergic function. Nicotine is administered to a subject initially having a blood s... | 12/03/1991 |
| 5002776 | Controlled absorption diltiazem formulations A controlled absorption diltiazem pellet formulation for oral administration comprises a core of diltiazem or a pharmaceutically acceptable salt thereof in association with an organic acid, and a multi-layer membrane surrounding the core and containing a ... | 03/26/1991 |
| 4973469 | Drug delivery system A controlled release formulation comprising an adsorbate of a mixture of a pharmaceutically useful active ingredient and an inactive substance adsorbed on a cross-linked polymer. The inactive substance is selected to modify the dissolution of the active i... | 11/27/1990 |
| 4952402 | Controlled release powder and process for its preparation A controlled release powder containing discrete micro-particles for use in edible, pharmaceutical and other controlled release compositions is disclosed. The micro-particles have an average size in the range of from 0.1 to 125 μm. Each of the micro-parti... | 08/28/1990 |
| 4940588 | Controlled release powder and process for its preparation A controlled release powder containing discrete micro-particles for use in edible, pharmaceutical and other controlled release compositions is disclosed. The micro-particles have an average size in the range of from 0.1 to 125 μm. Each of the micro-parti... | 07/10/1990 |
| 4917899 | Controlled absorption diltiazem formulation A diltiazem pellet formulation for oral administration comprises a core of diltiazem or a pharmaceutically acceptable salt thereof in association with an organic acid and a lubricant, and a membrane surrounding the core comprising a multiplicity of sequen... | 04/17/1990 |
| 4898737 | Controlled absorption pharmaceutical composition A sustained absorption propranolol-containing pellet for oral administration comprises a core of propranolol or a pharmaceutically acceptable salt thereof and an organic acid embedded in a polymeric material in a multi-layer arrangement and an outer membr... | 02/06/1990 |
| 4894240 | Controlled absorption diltiazem formulation for once-daily administration A diltiazem pellet formulation for oral administration comprises a core of diltiazem or a pharmaceutically acceptable salt thereof in association with an organic acid, and a multi-layer membrane surrounding the core and containing a major proportion of a ... | 01/16/1990 |
| 4891230 | Diltiazem formulation A diltiazem pellet formulation for oral administration comprises a core of diltiazem or a pharmaceutically acceptable salt thereof in association with an organic acid, and a multi-layer membrane surrounding the core and containing a major proportion of a ... | 01/02/1990 |
| 4863742 | Controlled absorption pharmaceutical composition A controlled absorption verapamil containing pellet formulation for oral adminstration comprises a core of a powder mixture containing verapamil or a pharmaceutically acceptable salt thereof and an organic acid and a polymeric material, said core comprisi... | 09/05/1989 |
| 4822617 | Drug delivery device A device for the unidirectional transdermal administration of a drug in an ointment, cream or jelly-like carrier comprising a laminar applicator adapted to receive a predetermined quantity of the drug on a skin-contacting surface thereof, the applicator i... | 04/18/1989 |
| 4769236 | Medicaments with a high degree of solubility and method for their production The present invention relates to medicaments with a high degree of dissolution rate and solubility. These medicaments are characterized in that they are in amorphous form produced by spraying in the presence of a stabilizer and of an agent inhibiting the ... | 09/06/1988 |
| 4592753 | Drug delivery device A device for transdermal administration of a drug comprises a reservoir containing the drug and a supporting strap, or band, which substantially surrounds a limb of the patient and holds the reservoir in position on a limb of the patient. The reservoir is... | 06/03/1986 |
